THE “WILL THIS TRIAL CHANGE MY PRACTICE?” SESSION AT EUROPCR 2019
The aim of this article is to capture the session at EuroPCR 2019, communicate the analysis of the trialists, and report the views expressed in the interactive discussion.
Introduction to the session
The last 17 years represent an unparalleled era of technological design and device iterations for valve intervention. Transcatheter aortic valve implantation (TAVI) has been explored in randomised controlled trials (RCTs) in an inverse fashion when compared with coronary angioplasty - starting with extreme- and high-risk patients, and progressively moving towards low-risk patients (Figure 1).
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com